2026-03-06 Chemical Collective

The Subtle Harms of Psychedelic-Assisted Therapy and Facilitation (Part 1)

Despite its cultural prestige and rapid commercial growth, psychotherapy – as well as psychedelic-assisted therapy – rests on overstated evidence, underreported harms, and inherent power imbalances that can produce subtle harms. The post The Subtle Harms of Psychedelic-Assisted Therapy and Facilitation (Part 1) appeared first on Chemical Collective.

External link. We are not responsible for the content.

Read more ↗

More From Chemical Collective

2026-04-19 Chemical Collective

Psychonautisme, Herbes et Suppléments

De nombreux aliments et compléments alimentaires courants contiennent des composés actifs qui interagissent avec la n...

2026-04-16 Chemical Collective

Psychedelics in the Age of Eco-Anxiety

Eco-anxiety is a rising response to environmental crises that can be transformed into resilience and action through s...

2026-04-13 Chemical Collective

Heartbreak is a Bad Trip

Oli Genn-Bash describes how the aftermath of a sudden breakup felt like a prolonged ‘bad trip’, as well as the potent...

Latest News

2026-04-20 Psychedelics Today

Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways

The White House moved to accelerate federal handling of psychedelic drugs, including ibogaine, while leaving core app...

2026-04-20 The Microdose (Berkeley)

Can an LLM get high? 5 Questions with clinical neuroscientist Ziv Ben-Zion

Ben-Zion discusses how artificial intelligence mimics the psychedelic experience.

2026-04-20 DoubleBlind Magazine

5 Things We Learned at Psychedelic Culture 2026

Plus, ketamine addiction, DMT lasers, and plant medicine faeries [...] Read More... The post 5 Things We Learned at P...

2026-04-19 The Psychedelic Blog (Substack)

Global Altered States: The Storefront Psychedelic

This week’s Sunday Insider: inside a storefront where Psychedelics are no longer a journey…they’re a choice.

2026-04-18 MAPS

MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy

April 18, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) issued the following statements fro...

2026-04-17 Psychedelics Today

Op-Ed: Iboga, Ibogaine & 5-MeO-DMT: What gets missed when complex medicines are reduced to standard protocols

What gets lost when iboga is reduced to ibogaine, and complex care is reduced to protocol? In this op-ed, Paije West ...